Literature DB >> 33923169

Tubulin Inhibitors: A Chemoinformatic Analysis Using Cell-Based Data.

Edgar López-López1,2, Carlos M Cerda-García-Rojas1, José L Medina-Franco2.   

Abstract

Inhibiting the tubulin-microtubules (Tub-Mts) system is a classic and rational approach for treating different types of cancers. A large amount of data on inhibitors in the clinic supports Tub-Mts as a validated target. However, most of the inhibitors reported thus far have been developed around common chemical scaffolds covering a narrow region of the chemical space with limited innovation. This manuscript aims to discuss the first activity landscape and scaffold content analysis of an assembled and curated cell-based database of 851 Tub-Mts inhibitors with reported activity against five cancer cell lines and the Tub-Mts system. The structure-bioactivity relationships of the Tub-Mts system inhibitors were further explored using constellations plots. This recently developed methodology enables the rapid but quantitative assessment of analog series enriched with active compounds. The constellations plots identified promising analog series with high average biological activity that could be the starting points of new and more potent Tub-Mts inhibitors.

Entities:  

Keywords:  activity landscape; analog series; cell-based assays; chemical space; chemoinformatics; constellation plots; drug discovery; microtubules; scaffold; structure–property relationships

Mesh:

Substances:

Year:  2021        PMID: 33923169     DOI: 10.3390/molecules26092483

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  45 in total

1.  Tubulin inhibitors: Discovery of a new scaffold targeting extra-binding residues within the colchicine site through anchoring substituents properly adapted to their pocket by a semi-flexible linker.

Authors:  Raed M Maklad; El-Shimaa M N AbdelHafez; Dalia Abdelhamid; Omar M Aly
Journal:  Bioorg Chem       Date:  2020-04-06       Impact factor: 5.275

Review 2.  Navigating structure-activity landscapes.

Authors:  Jürgen Bajorath; Lisa Peltason; Mathias Wawer; Rajarshi Guha; Michael S Lajiness; John H Van Drie
Journal:  Drug Discov Today       Date:  2009-05-03       Impact factor: 7.851

Review 3.  An overview of tubulin inhibitors that interact with the colchicine binding site.

Authors:  Yan Lu; Jianjun Chen; Min Xiao; Wei Li; Duane D Miller
Journal:  Pharm Res       Date:  2012-07-20       Impact factor: 4.200

4.  Quantitative structure-activity relationship (5D-QSAR) study of combretastatin-like analogues as inhibitors of tubulin assembly.

Authors:  Sylvie Ducki; Grant Mackenzie; Nicholas J Lawrence; James P Snyder
Journal:  J Med Chem       Date:  2005-01-27       Impact factor: 7.446

5.  Prediction of intracellular exposure bridges the gap between target- and cell-based drug discovery.

Authors:  André Mateus; Laurie J Gordon; Gareth J Wayne; Helena Almqvist; Hanna Axelsson; Brinton Seashore-Ludlow; Andrea Treyer; Pär Matsson; Thomas Lundbäck; Andy West; Michael M Hann; Per Artursson
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-12       Impact factor: 11.205

6.  Design, synthesis and bio-evaluation of novel 2-aryl-4-(3,4,5-trimethoxy-benzoyl)-5-substituted-1,2,3-triazoles as the tubulin polymerization inhibitors.

Authors:  Liancheng Huang; Meng Liu; Shuai Man; Deyi Ma; Dongjie Feng; Zhongqiao Sun; Qi Guan; Daiying Zuo; Yingliang Wu; Weige Zhang; Kai Bao
Journal:  Eur J Med Chem       Date:  2019-11-02       Impact factor: 6.514

7.  Synthesis, biological evaluation, and structure-activity relationships of tri- and tetrasubstituted olefins related to isocombretastatin A-4 as new tubulin inhibitors.

Authors:  Jessy Aziz; Etienne Brachet; Abdallah Hamze; Jean-François Peyrat; Guillaume Bernadat; Estelle Morvan; Jérôme Bignon; Joanna Wdzieczak-Bakala; Déborah Desravines; Joelle Dubois; Marie Tueni; Ahmad Yassine; Jean-Daniel Brion; Mouad Alami
Journal:  Org Biomol Chem       Date:  2012-10-09       Impact factor: 3.876

8.  Discovery of a chiral fluorinated azetidin-2-one as a tubulin polymerisation inhibitor with potent antitumour efficacy.

Authors:  Hairong Tang; Jiayi Cheng; Yuru Liang; Yang Wang
Journal:  Eur J Med Chem       Date:  2020-04-18       Impact factor: 6.514

9.  Design, synthesis and structure-activity relationship of 3,6-diaryl-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines as novel tubulin inhibitors.

Authors:  Qile Xu; Kai Bao; Maolin Sun; Jingwen Xu; Yueting Wang; Haiqiu Tian; Daiying Zuo; Qi Guan; Yingliang Wu; Weige Zhang
Journal:  Sci Rep       Date:  2017-09-20       Impact factor: 4.379

10.  Structure-Activity Relationship Studies of β-Lactam-azide Analogues as Orally Active Antitumor Agents Targeting the Tubulin Colchicine Site.

Authors:  Dong-Jun Fu; Ling Fu; Ying-Chao Liu; Jun-Wei Wang; Yu-Qing Wang; Bing-Kai Han; Xiao-Rui Li; Chuang Zhang; Feng Li; Jian Song; Bing Zhao; Ruo-Wang Mao; Ruo-Han Zhao; Sai-Yang Zhang; Li Zhang; Yan-Bing Zhang; Hong-Min Liu
Journal:  Sci Rep       Date:  2017-10-06       Impact factor: 4.379

View more
  2 in total

Review 1.  Two Important Anticancer Mechanisms of Natural and Synthetic Chalcones.

Authors:  Teodora Constantinescu; Alin Grig Mihis
Journal:  Int J Mol Sci       Date:  2022-09-30       Impact factor: 6.208

2.  In vitro characterization and rational analog design of a novel inhibitor of telomerase assembly in MDA MB 231 breast cancer cell line.

Authors:  Daniel Gomez; Diego Mengual Gómez; Romina Armando; Maia Cabrera; Roman Vilarullo; Patricio Chinestrad; Julian Maggio; Camila Paderta; Pablo Lorenzano Menna
Journal:  Oncol Rep       Date:  2022-09-14       Impact factor: 4.136

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.